A detailed history of Aspire Private Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Aspire Private Capital, LLC holds 220 shares of NVO stock, worth $26,567. This represents 0.01% of its overall portfolio holdings.

Number of Shares
220
Previous 219 0.46%
Holding current value
$26,567
Previous $28,000 10.71%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

BUY
$122.71 - $146.91 $122 - $146
1 Added 0.46%
220 $31,000
Q1 2024

Apr 18, 2024

BUY
$102.11 - $135.92 $2,450 - $3,262
24 Added 12.31%
219 $28,000
Q4 2023

Feb 01, 2024

SELL
$87.78 - $105.45 $1,316 - $1,581
-15 Reduced 7.14%
195 $20,000
Q3 2023

Nov 03, 2023

BUY
$90.94 - $199.54 $9,457 - $20,752
104 Added 98.11%
210 $19,000
Q2 2023

Jul 24, 2023

SELL
$155.98 - $172.65 $467 - $517
-3 Reduced 2.75%
106 $17,000
Q1 2023

May 30, 2023

BUY
$132.34 - $159.14 $661 - $795
5 Added 4.81%
109 $17,000
Q1 2023

May 03, 2023

BUY
$132.34 - $159.14 $661 - $795
5 Added 4.81%
109 $17,000
Q4 2022

May 30, 2023

SELL
$102.55 - $135.33 $512 - $676
-5 Reduced 4.59%
104 $14,000
Q3 2022

Nov 10, 2022

SELL
$95.28 - $116.93 $381 - $467
-4 Reduced 3.7%
104 $10,000
Q1 2022

May 10, 2022

BUY
$93.1 - $112.54 $2,793 - $3,376
30 Added 38.46%
108 $12,000
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $1,534 - $1,873
16 Added 25.81%
78 $9,000
Q2 2021

Aug 09, 2021

SELL
$67.66 - $84.76 $135 - $169
-2 Reduced 3.13%
62 $5,000
Q1 2021

May 26, 2021

BUY
$67.06 - $75.82 $4,023 - $4,549
60 Added 1500.0%
64 $4,000
Q4 2020

Feb 16, 2021

BUY
$63.89 - $73.8 $63 - $73
1 Added 33.33%
4 $0
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $4,012 - $4,423
-63 Reduced 95.45%
3 $0
Q2 2020

Aug 13, 2020

BUY
$58.54 - $67.94 $3,629 - $4,212
62 Added 1550.0%
66 $4,000
Q1 2020

May 14, 2020

SELL
$49.46 - $64.78 $494 - $647
-10 Reduced 71.43%
4 $0
Q4 2019

Feb 11, 2020

BUY
$49.86 - $58.26 $698 - $815
14 New
14 $1,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $273B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Aspire Private Capital, LLC Portfolio

Follow Aspire Private Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aspire Private Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aspire Private Capital, LLC with notifications on news.